Min Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 8
- Circular RNAs in diseases 7
- Extracellular vesicles in disease 7
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5
- Co-authors
- Yiping Wu (32 shared papers)Wenchang Lv (14 shared papers)Mingchen Xiong (12 shared papers)Weijie Hu (11 shared papers)Qi Zhang (20 shared papers)Chongru Zhao (10 shared papers)Yi Yi (9 shared papers)Yi Yi (5 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (3 papers)PLoS ONE (3 papers)Oncotarget (3 papers)International Journal of Nanomedicine (3 papers)Frontiers in Immunology (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Min Wu
95 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 450
- Immunology 343
- Rehabilitation 102
- Dermatology 118
- Molecular Biology 839
Countries citing papers authored by Min Wu
This map shows the geographic impact of Min Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Wu more than expected).
Fields of papers citing papers by Min Wu
This network shows the impact of papers produced by Min Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Wu. The network helps show where Min Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 121 | |
| 2 | 2019 | 112 | |
| 3 | 2021 | 106 | |
| 4 | 2020 | 97 | |
| 5 | 2015 | 96 | |
| 6 | 2017 | 80 | |
| 7 | 2020 | 66 | |
| 8 | 2015 | 62 | |
| 9 | 2010 | 48 | |
| 10 | 2012 | 47 | |
| 11 | 2013 | 44 | |
| 12 | 2021 | 43 | |
| 13 | 2015 | 43 | |
| 14 | 2021 | 42 | |
| 15 | 2019 | 38 | |
| 16 | 2018 | 34 | |
| 17 | 2019 | 33 | |
| 18 | 2021 | 30 | |
| 19 | 2017 | 30 | |
| 20 | 2022 | 29 |
About Min Wu
Min Wu is a scholar working on Molecular Biology, Cancer Research, Immunology, Surgery and Pulmonary and Respiratory Medicine, having authored 100 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Mesenchymal stem cell research (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (7 papers), Extracellular vesicles in disease (7 papers), Wound Healing and Treatments (5 papers), MicroRNA in disease regulation (5 papers) and Systemic Lupus Erythematosus Research (5 papers). The work is most often cited by research in Cancer Research (450 citations), Immunology (343 citations), Rehabilitation (102 citations), Dermatology (118 citations) and Molecular Biology (839 citations). Min Wu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yiping Wu, Wenchang Lv, Mingchen Xiong, Weijie Hu, Qi Zhang, Chongru Zhao, Yi Yi, Yi Yi, Yufang Tan and Qi Zhang. Their work appears in journals such as Frontiers in Cell and Developmental Biology, PLoS ONE, Oncotarget, International Journal of Nanomedicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.